Pathogenic factors such as lipotoxicity, insulin resistance, oxidative stress, and gut microbiota alterations contribute to both conditions
custom protocols offer dose-adjustment flexibility but require managing multiple reconstitutions and schedules
Depending on provider evaluation, eligible patients may discuss Tirzepatide, Semaglutide, Mounjaro, Zepbound, Wegovy, Ozempic, lifestyle modifications, nutrition support, and ongoing follow-up care as part of a personalized medical weight loss program
As its name suggests, IGF-1 is structurally similar to insulin and is capable of binding to the insulin receptor (I-R), albeit with a lower affinity than that towards IGF-1R
GLP-1s like Ozempic and Wegovy also impact gastric emptying by allowing food to stay in your stomach (and make you feel full) longer
[1] [3] However, the gastrointestinal effects of these drugsincluding nausea, vomiting, diarrhea, and constipationcan potentially affect nutrient absorption and electrolyte balance